Instrumentation Laboratory (IL) has released the Hemosil HIT-Ab(PF4-H) assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices.
Delivering results in minutes, the Hemosil HIT-Ab(PF4-H) assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes - the antibodies associated with the pathology of HIT.
Hemosil HIT-Ab(PF4-H) is said to be the first on-demand, fully automated assay for HIT antibody detection on hemostasis testing systems.
Unlike existing manual processes, Hemosil HIT-Ab(PF4-H) assay is liquid and ready to use, provides results in minutes and is available 24hrs a day, seven days a week.
The assay is designed exclusively for the ACL TOP range of Hemostasis Testing Systems, ensuring simplicity and efficiency throughout the testing process.
IL's GEM product offerings, part of the critical care line, include the GEM Premier 3500 with Intelligent Quality Management (iQM), GEM Premier 4000 analyser, GEMweb Plus Custom Connectivity and the GEM PCL Plus, a portable coagulation analyser.
IL's hemostasis portfolio includes the ACL TOP range of Hemostasis testing systems, including the ACL TOP 700, the ACL TOP 700 LAS and the ACL TOP 500 CTS.
IL also offers the ACL Acustar, ACL Elite and Elite Pro, and other hemostasis analysers.
